Literature DB >> 28972596

Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.

Luke Martin1, William Peche1, Kathryn Peterson2, Yuan Wan3, Stephanie Chan2, Ryan Morton2, Chong Zhang4, Angela P Presson4, James Hotaling1,5.   

Abstract

OBJECTIVES: Crohn's disease (CD) and ulcerative colitis (UC) impact an estimated 350,000 reproductive age men in the United States. The reproductive consequences are largely unknown. The objective of this study was to evaluate the effects of CD and UC on reproductive outcomes.
METHODS: From the Utah Population Database, we identified a cohort of male patients with CD (1,245) and UC (1,368). Male-sibling controls were identified, and birth outcome data from offspring were obtained. Analyses for CD and UC were completed separately.
RESULTS: Among UC patients (473) with at least one male sibling (1,020), 66% had offspring, which was not different compared with siblings (61%, P=0.16). Birth outcomes were not different between UC patients and male siblings: congenital malformations (UC 6% vs. 6%, P=0.99), perinatal complications (UC 35% vs. 31%, P=0.23), mean birth weight (UC 3,347 vs. 3,357 g, P=0.53), mean length of gestation (UC 39.0 vs. 39.1 weeks, P=0.54). Among CD patients (421) with at least one male sibling (833), 58% had offspring, which did not differ compared with siblings (57%, P=0.77). Similarly, there were no differences in partner birth outcomes: congenital malformations (CD 7% vs. 6%, P=0.27), perinatal complications (CD 35% vs. 32%, P=0.12), mean birth weight (CD 3,276 vs. 3,324 g, P=0.13), or mean length of gestation (38.8 vs. 39 weeks, P=0.24).
CONCLUSIONS: We found no differences in paternity rate or female partner birth outcomes in Utah men with UC or CD compared with male-sibling controls. UC and CD do not appear to affect the reproductive outcomes of men in Utah.

Entities:  

Mesh:

Year:  2017        PMID: 28972596     DOI: 10.1038/ajg.2017.279

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

Review 1.  Management of inflammatory bowel disease in pregnancy.

Authors:  Séverine Vermeire; Franck Carbonnel; Pierre G Coulie; Vincent Geenen; Johanna M W Hazes; Pierre L Masson; Filip De Keyser; Edouard Louis
Journal:  J Crohns Colitis       Date:  2012-05-16       Impact factor: 9.071

2.  Antisperm antibodies in inflammatory bowel disease.

Authors:  Marco Rossato; Carlo Foresta
Journal:  Arch Intern Med       Date:  2004-11-08

3.  Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients.

Authors:  Willem E Hueting; Erik Buskens; Ingeborg van der Tweel; Hein G Gooszen; Cees J H M van Laarhoven
Journal:  Dig Surg       Date:  2005-04-14       Impact factor: 2.588

4.  Male infertility due to sulphasalazine.

Authors:  A J Levi; A M Fisher; L Hughes; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

5.  Sulphasalazine and male infertility: reversibility and possible mechanism.

Authors:  S Toovey; E Hudson; W F Hendry; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

6.  Reversible male infertility due to sulphasalazine: studies in man and rat.

Authors:  C O'Moráin; P Smethurst; C J Doré; A J Levi
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

7.  Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease.

Authors:  Ian Lindsey; Bruce George; Michael Kettlewell; Neil Mortensen
Journal:  Dis Colon Rectum       Date:  2002-06       Impact factor: 4.585

Review 8.  Sexual and reproductive issues for men with inflammatory bowel disease.

Authors:  Linda A Feagins; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2009-02-17       Impact factor: 10.864

9.  Male infertility in inflammatory bowel disease.

Authors:  M Narendranathan; R S Sandler; C M Suchindran; D A Savitz
Journal:  J Clin Gastroenterol       Date:  1989-08       Impact factor: 3.062

10.  The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.

Authors:  B Nørgård; L Pedersen; J Jacobsen; S N Rasmussen; H T Sørensen
Journal:  Aliment Pharmacol Ther       Date:  2004-03-15       Impact factor: 8.171

View more
  1 in total

Review 1.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.